Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07018726 · ClinicalTrials.gov registry record · NA
Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
A NA study of Young Onset Dementia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 388
- Enrollment target
- 1
- Study location
NCT07018726 is a NA study of Young Onset Dementia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 388 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07018726, a NA study of Young Onset Dementia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 388 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to address the unmet need of preventing chronic emotional distress in YOD dyads through a feasible, acceptable and credible program, and ideally enhance resiliency and improve wellbeing and quality of life in both members of the dyad.
Conditions Studied
Interventions
- BEHAVIORAL Resilient Together-YOD
- BEHAVIORAL Health Enhancement Program-YOD
Study Locations (1)
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2026-01-28 |
| Est. Completion | 2031-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07018726
The ClinicalTrials.gov registry entry for NCT07018726 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Young Onset Dementia appearing as the primary indexed condition, and to 2 interventions - of which Resilient Together-YOD is the first listed.
NCT07018726 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07018726 about?
NCT07018726 is a clinical study titled "Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners". The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to addre...
What is the current status of trial NCT07018726?
This trial is currently recruiting. It is a NA study. The enrollment target is 388 participants. The study started on 2026-01-28. Estimated completion is 2031-01-01.
What conditions does trial NCT07018726 study?
This clinical trial studies the following conditions: Young Onset Dementia.
What interventions are being tested in trial NCT07018726?
The interventions under investigation include: Resilient Together-YOD (BEHAVIORAL), Health Enhancement Program-YOD (BEHAVIORAL).
Who is sponsoring clinical trial NCT07018726?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07018726 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.